Glenview Likes AbbVie, Brookdale And Marty Lipton

Larry Robbins’ Glenview Capital Management’s Opportunity Fund delivered 7.2% during the first quarter, significantly outperforming the S&P 500. In this article, I’m taking a closer look at some of the fund’s top calls during the quarter and outlook for the rest of the year. If you’re interested in a condensed version of the fund’s performance during the quarter, ValueWalk author, Mark Melin has put together a brief overview here. Glenview: AbbVie After talking up AbbVie at the Sohn Conference earlier this year, Larry Robbins continued to tout the stock in Glenview’s first quarter letter. Robbins says that he sees a…